Alderley Edge, United Kingdom
Apex Molecular Ltd, founded in 2011, is a leading UK-based CRO (Contract Research Organisation) that offers specialized chemistry synthesis services catering to the Life Science industry. Their headquarters are located in the United Kingdom.
They boast a strong portfolio, providing services to sectors like pharmaceutical, biotechnology, and applied chemistry. Apex Molecular caters to clients such as drug discovery, biotech, and agritech companies. They excel by integrating services seamlessly into client operations, enhancing R&D efficiency and reducing project risk.
The company offers services including Custom/Contract Synthesis, Medicinal Chemistry, and Highly potent API synthesis. Their high-potency facilities feature specialized infrastructure, reinforcing their role in customized chemical solutions, particularly for antibody-drug conjugates.
Their last financing occurred on 30 October 2018, a £250.00K Debt Financing round, supported by the Northern Powerhouse Investment Fund. Apex Molecular represents a sound investment in the dynamic life science sector, maintaining cutting-edge facilities with robust industry relations.
CanAm Bioresearch Inc.
